Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Mebendazole | hsa00010 | Glycolysis / Gluconeogenesis | 1.18E-02 | 2 | P60174, P06744 | TPI1, GPI | More | | Mebendazole | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Mebendazole | hsa00053 | Ascorbate and aldarate metabolism | 1.20E-03 | 3 | P51648, P14550, Q9UEF7 | ALDH3A2, AKR1A1, KL | More | | Mebendazole | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | | Mebendazole | hsa00220 | Arginine biosynthesis | 3.21E-04 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Mebendazole | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Mebendazole | hsa00310 | Lysine degradation | 4.27E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Mebendazole | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Mebendazole | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Mebendazole | hsa00561 | Glycerolipid metabolism | 4.36E-03 | 3 | O14494, P51648, P23743 | PLPP1, ALDH3A2, DGKA | More | | Mebendazole | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Mebendazole | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | | Mebendazole | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.25E-04 | 2 | P40925, P15104 | MDH1, GLUL | More | | Mebendazole | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Mebendazole | hsa00910 | Nitrogen metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Mebendazole | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.24E-03 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | | Mebendazole | hsa01200 | Carbon metabolism | 1.99E-02 | 2 | P06744, P60174 | GPI, TPI1 | More | | Mebendazole | hsa01230 | Biosynthesis of amino acids | 5.53E-03 | 2 | P15104, P37837 | GLUL, TALDO1 | More | | Mebendazole | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.14E-02 | 4 | P17252, P08069, P10415, Q9NRA1 | PRKCA, IGF1R, BCL2, PDGFC | More | | Mebendazole | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa01524 | Platinum drug resistance | 4.79E-03 | 6 | Q13315, P10415, Q13489, P98170, P78417, P43246 | ATM, BCL2, BIRC3, BIRC4, GSTO1, MSH2 | More | | Mebendazole | hsa02010 | ABC transporters | 2.17E-03 | 1 | Q8IZY2 | ABCA7 | More | | Mebendazole | hsa03013 | RNA transport | 5.22E-03 | 12 | P52298, Q09161, O14893, P38919, P37198, Q7Z3B4, P35658, Q14152, P55884, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, EIF4A3, NUP62, NUP54, NUP214, EIF3A, EIF3B, EIF3J, RPP38, TACC3 | More | | Mebendazole | hsa03040 | Spliceosome | 2.18E-10 | 15 | Q14562, O43143, O60508, P08579, P26368, P52298, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, NCBP2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13509 | TUBB3 | Tubulin beta-3 chain | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.922 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.717 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.809 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | Q13509 | TUBB3 | Tubulin beta-3 chain | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.878 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | Q13509 | TUBB3 | Tubulin beta-3 chain | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.784 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.766 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.702 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | Q13509 | TUBB3 | Tubulin beta-3 chain | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | -0.818 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.814 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.879 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.806 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | Q13509 | TUBB3 | Tubulin beta-3 chain | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | Q13509 | TUBB3 | Tubulin beta-3 chain | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.87 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.783 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.703 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.823 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | Q13509 | TUBB3 | Tubulin beta-3 chain | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.749 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.76 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | Q13509 | TUBB3 | Tubulin beta-3 chain | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.724 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Mebendazole | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Mebendazole | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Mebendazole | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04014 | Ras signaling pathway | 1.13E-02 | 9 | P42338, P20827, P49767, P08069, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, IGF1R, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Mebendazole | hsa04015 | Rap1 signaling pathway | 7.59E-04 | 11 | P20827, P49767, P08069, P06213, Q96FS4, P11215, Q13009, O00522, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, IGF1R, INSR, SIPA1, ITGAM, TIAM1, KRIT1, RASGRP2, PIK3CB, PLCG1 | More | | Mebendazole | hsa04020 | Calcium signaling pathway | 2.09E-02 | 5 | Q16566, P17252, P25116, P0DP23, Q9NRA1 | CAMK4, PRKCA, F2R, CALM1, PDGFC | More | | Mebendazole | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Mebendazole | hsa04062 | Chemokine signaling pathway | 7.15E-05 | 15 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Mebendazole | hsa04064 | NF-kappa B signaling pathway | 2.53E-07 | 20 | P10415, Q13489, P25963, P51617, O00463, Q13546, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P24522, O75293, P09341, P19875, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, RIPK1, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, GADD45A, GADD45B, CXCL1, CXCL2, LTB | More | | Mebendazole | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04071 | Sphingolipid signaling pathway | 5.66E-04 | 8 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, P01042 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, KNG1 | More | | Mebendazole | hsa04072 | Phospholipase D signaling pathway | 1.54E-03 | 10 | P42338, P43657, P25116, P25024, P25025, P19174, P17252, O14494, P23743, Q9NRA1 | PIK3CB, P2RY5, F2R, CXCR1, CXCR2, PLCG1, PRKCA, PLPP1, DGKA, PDGFC | More | | Mebendazole | hsa04080 | Neuroactive ligand-receptor interaction | 1.18E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1 | More | | Mebendazole | hsa04114 | Oocyte meiosis | 3.19E-03 | 5 | P51812, Q02750, P16298, Q17RY0, P08069 | RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | | Mebendazole | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Mebendazole | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04141 | Protein processing in endoplasmic reticulum | 2.77E-02 | 5 | P27824, P30101, P60604, P11142, P08238 | CANX, PDIA3, UBE2G2, HSPA8, HSP90AB1 | More | | Mebendazole | hsa04142 | Lysosome | 2.64E-02 | 2 | Q99437, P25774 | ATP6V0B, CTSS | More | | Mebendazole | hsa04145 | Phagosome | 1.22E-04 | 12 | Q15080, P14598, Q13509, P68371, Q13488, Q99437, P05164, O60603, P35443, P27824, P13765, P25774 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, ATP6V0B, MPO, TLR2, THBS4, CANX, HLA-DOB, CTSS | More | | Mebendazole | hsa04150 | mTOR signaling pathway | 7.74E-03 | 4 | P08069, Q02750, Q9NQL2, P51812 | IGF1R, MAP2K1, RRAGD, RPS6KA3 | More | | Mebendazole | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Mebendazole | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04210 | Apoptosis | 1.52E-02 | 9 | Q13315, P10415, Q13489, P25963, P01375, P24522, Q16548, Q13077, Q14643 | ATM, BCL2, BIRC3, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, ITPR1 | More | | Mebendazole | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04213 | Longevity regulating pathway - multiple species | 1.17E-02 | 5 | P42338, P08069, Q9Y4H2, P11142, Q13547 | PIK3CB, IGF1R, IRS2, HSPA8, HDAC1 | More | | Mebendazole | hsa04217 | Necroptosis | 1.82E-06 | 11 | P01568, Q13489, P98170, Q13546, P42224, P08238, P15104, Q6FI13, P10415, O43633, P21796 | IFNA21, BIRC3, BIRC4, RIPK1, STAT1, HSP90AB1, GLUL, H2AC18; H2AC19, BCL2, CHMP2A, VDAC1 | More | | Mebendazole | hsa04330 | Notch signaling pathway | 2.77E-02 | 2 | Q92542, P49768 | NCSTN, PSEN1 | More | | Mebendazole | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Mebendazole | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Mebendazole | hsa04371 | Apelin signaling pathway | 9.81E-08 | 11 | P62873, P63218, P50151, Q8WYR1, Q13370, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Mebendazole | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Mebendazole | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04520 | Adherens junction | 7.00E-04 | 5 | Q13485, P84022, O95863, P08069, Q15223 | SMAD4, SMAD3, SNAI1, IGF1R, PVRL1 | More | | Mebendazole | hsa04540 | Gap junction | 5.44E-03 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Mebendazole | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04610 | Complement and coagulation cascades | 4.27E-06 | 1 | P0C0L4 | C4A | More | | Mebendazole | hsa04612 | Antigen processing and presentation | 8.21E-03 | 5 | P26715, P26717, Q07444, Q13241, P01732 | KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | | Mebendazole | hsa04613 | Neutrophil extracellular trap formation | 1.30E-03 | 13 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, P14598, Q15080, P20160, P08311, P49913, P21730, P21462 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | | Mebendazole | hsa04620 | Toll-like receptor signaling pathway | 7.24E-03 | 5 | P51617, Q13546, P01568, P42224, P25963 | IRAK1, RIPK1, IFNA21, STAT1, NFKBIA | More | | Mebendazole | hsa04621 | NOD-like receptor signaling pathway | 4.64E-04 | 15 | P08238, Q14643, P42224, P01568, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q13546, Q05823, P01375, P49913, P12838 | HSP90AB1, ITPR1, STAT1, IFNA21, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RIPK1, RNASEL, TNF, CAMP, DEFA4 | More | | Mebendazole | hsa04623 | Cytosolic DNA-sensing pathway | 4.52E-05 | 3 | P01568, Q13546, P25963 | IFNA21, RIPK1, NFKBIA | More | | Mebendazole | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Mebendazole | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Mebendazole | hsa04650 | Natural killer cell mediated cytotoxicity | 6.36E-08 | 14 | P16298, P50591, P19174, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O14931, P26717, Q07444, P26715 | PPP3CB, TNFSF10, PLCG1, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KLRC1 | More | | Mebendazole | hsa04657 | IL-17 signaling pathway | 1.36E-02 | 5 | O00463, Q16539, P49841, P14780, P01375 | TRAF5, MAPK14, GSK3B, MMP9, TNF | More | | Mebendazole | hsa04658 | Th1 and Th2 cell differentiation | 6.40E-08 | 10 | Q04759, P07766, P20963, P09693, P19174, P06239, P23771, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, GATA3, TBX21, IL2RB, RUNX3 | More | | Mebendazole | hsa04659 | Th17 cell differentiation | 7.23E-08 | 13 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Mebendazole | hsa04660 | T cell receptor signaling pathway | 3.97E-06 | 15 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK | More | | Mebendazole | hsa04662 | B cell receptor signaling pathway | 1.74E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Mebendazole | hsa04664 | Fc epsilon RI signaling pathway | 1.78E-04 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Mebendazole | hsa04666 | Fc gamma R-mediated phagocytosis | 2.81E-02 | 4 | P23528, O14494, P14598, P17252 | CFL1, PLPP1, NCF1, PRKCA | More | | Mebendazole | hsa04668 | TNF signaling pathway | 1.83E-03 | 8 | P01375, O00463, Q13489, Q16539, P25963, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, BCL3, TRAF1, MMP9 | More | | Mebendazole | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Mebendazole | hsa04710 | Circadian rhythm | 1.79E-02 | 1 | O15516 | CLOCK | More | | Mebendazole | hsa04713 | Circadian entrainment | 1.78E-03 | 5 | O15399, P0DP23, P62873, P63218, P50151 | GRIN2D, CALM1, GNB1, GNG5, GNG10 | More | | Mebendazole | hsa04720 | Long-term potentiation | 5.53E-05 | 7 | P17252, Q16566, P16298, P0DP23, P51812, O15399, Q02750 | PRKCA, CAMK4, PPP3CB, CALM1, RPS6KA3, GRIN2D, MAP2K1 | More | | Mebendazole | hsa04724 | Glutamatergic synapse | 2.00E-04 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | | Mebendazole | hsa04725 | Cholinergic synapse | 1.97E-04 | 6 | P17252, P62873, P63218, P50151, Q16566, P10415 | PRKCA, GNB1, GNG5, GNG10, CAMK4, BCL2 | More | | Mebendazole | hsa04726 | Serotonergic synapse | 2.38E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Mebendazole | hsa04727 | GABAergic synapse | 6.18E-04 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Mebendazole | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa04744 | Phototransduction | 5.98E-07 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Mebendazole | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Mebendazole | hsa04913 | Ovarian steroidogenesis | 8.40E-04 | 2 | P06213, P08069 | INSR, IGF1R | More | | Mebendazole | hsa04914 | Progesterone-mediated oocyte maturation | 5.89E-03 | 4 | P08069, Q17RY0, P51812, Q02750 | IGF1R, CPEB4, RPS6KA3, MAP2K1 | More | | Mebendazole | hsa04916 | Melanogenesis | 2.90E-02 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | | Mebendazole | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Mebendazole | hsa04923 | Regulation of lipolysis in adipocytes | 4.24E-03 | 4 | P07550, P06213, P42338, Q9Y4H2 | ADRB2, INSR, PIK3CB, IRS2 | More | | Mebendazole | hsa04925 | Aldosterone synthesis and secretion | 3.91E-02 | 3 | P0DP23, P17252, Q16566 | CALM1, PRKCA, CAMK4 | More | | Mebendazole | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Mebendazole | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Mebendazole | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | | Mebendazole | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.22E-02 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Mebendazole | hsa04964 | Proximal tubule bicarbonate reclamation | 2.17E-03 | 1 | P00918 | CA2 | More | | Mebendazole | hsa04966 | Collecting duct acid secretion | 2.17E-03 | 1 | P00918 | CA2 | More | | Mebendazole | hsa04970 | Salivary secretion | 4.49E-02 | 4 | P22694, Q14643, P17252, P49913 | PRKACB, ITPR1, PRKCA, CAMP | More | | Mebendazole | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Mebendazole | hsa05032 | Morphine addiction | 1.51E-03 | 4 | P62873, P63218, P50151, P43250 | GNB1, GNG5, GNG10, GRK6 | More | | Mebendazole | hsa05034 | Alcoholism | 3.87E-03 | 7 | O15399, Q16566, P0DP23, P62873, P63218, P50151, Q93079 | GRIN2D, CAMK4, CALM1, GNB1, GNG5, GNG10, H2BC9 | More | | Mebendazole | hsa05110 | Vibrio cholerae infection | 4.78E-02 | 1 | Q99437 | ATP6V0B | More | | Mebendazole | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Mebendazole | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Mebendazole | hsa05132 | Salmonella infection | 4.49E-06 | 15 | P51617, P25963, P01375, P08238, Q9UJU2, Q13546, Q13489, P10415, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, NFKBIA, TNF, HSP90AB1, LEF1, RIPK1, BIRC3, BCL2, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Mebendazole | hsa05133 | Pertussis | 3.02E-03 | 1 | P0C0L4 | C4A | More | | Mebendazole | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Mebendazole | hsa05140 | Leishmaniasis | 1.80E-04 | 9 | P14598, P42224, P13765, O60603, P25963, P01375, P29350, P51617, Q15080 | NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, IRAK1, NCF4 | More | | Mebendazole | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Mebendazole | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Mebendazole | hsa05145 | Toxoplasmosis | 1.84E-03 | 9 | P51617, P25963, P01375, P10415, Q13489, P42224, P13765, P11142, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, STAT1, HLA-DOB, HSPA8, TLR2 | More | | Mebendazole | hsa05146 | Amoebiasis | 2.37E-05 | 9 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1, CTSG | More | | Mebendazole | hsa05150 | Staphylococcus aureus infection | 1.31E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | | Mebendazole | hsa05152 | Tuberculosis | 3.89E-05 | 15 | Q13488, Q99437, P0DP23, P42224, P48382, P25208, O60603, P01375, P10415, P13765, P25774, P01568, P49913, Q9UDY8, P51617 | TCIRG1, ATP6V0B, CALM1, STAT1, RFX5, NFYB, TLR2, TNF, BCL2, HLA-DOB, CTSS, IFNA21, CAMP, MALT1, IRAK1 | More | | Mebendazole | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Mebendazole | hsa05162 | Measles | 4.50E-03 | 8 | P51617, P01568, P25963, P42224, P14784, P10747, P11142, P10415 | IRAK1, IFNA21, NFKBIA, STAT1, IL2RB, CD28, HSPA8, BCL2 | More | | Mebendazole | hsa05163 | Human cytomegalovirus infection | 1.64E-03 | 12 | P01375, P62873, P63218, P50151, P0DP23, P49841, P14778, P25025, Q16539, O00463, P30101, P01568 | TNF, GNB1, GNG5, GNG10, CALM1, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5, PDIA3, IFNA21 | More | | Mebendazole | hsa05166 | Human T-cell leukemia virus 1 infection | 1.77E-02 | 8 | P27824, P30279, P21796, P84022, Q13485, P07766, Q92830, P06746 | CANX, CCND2, VDAC1, SMAD3, SMAD4, CD3E, KAT2A, POLB | More | | Mebendazole | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.12E-03 | 10 | P01568, P62873, P62879, P63218, P50151, P16298, Q02750, P07948, P0DP23, P0CG47 | IFNA21, GNB1, GNB2, GNG5, GNG10, PPP3CB, MAP2K1, LYN, CALM1, UBB | More | | Mebendazole | hsa05168 | Herpes simplex virus 1 infection | 1.15E-04 | 17 | P25963, P01568, P42224, Q07955, Q01130, P84103, Q13243, Q13489, P51617, P30101, Q13398, Q9NR11, P17097, P17038, Q03923, Q9NZL3, P10415 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS3, SFRS5, BIRC3, IRAK1, PDIA3, ZNF211, ZNF302, ZNF7, ZNF43, ZNF85, ZNF224, BCL2 | More | | Mebendazole | hsa05170 | Human immunodeficiency virus 1 infection | 3.38E-10 | 26 | Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, P01375, Q05397, P17252, Q13546, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, O95067, P23528, P10415, Q13619, Q93034, Q9Y6Q5, P20333 | MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, TNF, PTK2, PRKCA, RIPK1, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CCNB2, CFL1, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1B | More | | Mebendazole | hsa05200 | Pathways in cancer | 3.43E-09 | 35 | P04628, Q13751, P42338, P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, P20585, Q13547, P14923, P30279, P30281, P10415, Q13489, P98170, P49767, Q12778, P43657, P25116, P62873, P63218, P50151, Q14344, Q7LDG7, P78417, O75293, P0DP23, P01568, P14784, P01042 | WNT1, LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, MSH3, HDAC1, JUP, CCND2, CCND3, BCL2, BIRC3, BIRC4, VEGFC, FOXO1, P2RY5, F2R, GNB1, GNG5, GNG10, GNA13, RASGRP2, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13509 | TUBB3 | Tubulin beta-3 chain | P04628 | WNT1 | Proto-oncogene Wnt-1 | -0.709 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.748 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.866 | P68371 | TUBB2C | Tubulin beta-4B chain | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.741 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | Q13509 | TUBB3 | Tubulin beta-3 chain | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.789 | Q13509 | TUBB3 | Tubulin beta-3 chain | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.733 | Q13509 | TUBB3 | Tubulin beta-3 chain | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.714 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P68371 | TUBB2C | Tubulin beta-4B chain | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | -0.714 | P68371 | TUBB2C | Tubulin beta-4B chain | P17252 | PRKCA | Protein kinase C alpha type | -0.842 | Q13509 | TUBB3 | Tubulin beta-3 chain | P17252 | PRKCA | Protein kinase C alpha type | -0.756 | P68371 | TUBB2C | Tubulin beta-4B chain | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.709 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | Q13509 | TUBB3 | Tubulin beta-3 chain | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.872 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.819 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.777 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P20585 | MSH3 | DNA mismatch repair protein Msh3 | -0.745 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P68371 | TUBB2C | Tubulin beta-4B chain | P14923 | JUP | Junction plakoglobin | -0.781 | Q13509 | TUBB3 | Tubulin beta-3 chain | P14923 | JUP | Junction plakoglobin | -0.937 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P30279 | CCND2 | G1/S-specific cyclin-D2 | -0.721 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P68371 | TUBB2C | Tubulin beta-4B chain | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | Q13509 | TUBB3 | Tubulin beta-3 chain | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.809 | P68371 | TUBB2C | Tubulin beta-4B chain | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.892 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q13509 | TUBB3 | Tubulin beta-3 chain | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P68371 | TUBB2C | Tubulin beta-4B chain | Q12778 | FOXO1 | Forkhead box protein O1 | -0.895 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P68371 | TUBB2C | Tubulin beta-4B chain | P25116 | F2R | Proteinase-activated receptor 1 | -0.799 | P68371 | TUBB2C | Tubulin beta-4B chain | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | Q13509 | TUBB3 | Tubulin beta-3 chain | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.816 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.818 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.827 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.879 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | Q13509 | TUBB3 | Tubulin beta-3 chain | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.826 | P68371 | TUBB2C | Tubulin beta-4B chain | P0DP23 | CALM1 | Calmodulin-1 | 0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | Q13509 | TUBB3 | Tubulin beta-3 chain | P0DP23 | CALM1 | Calmodulin-1 | 0.892 | P68371 | TUBB2C | Tubulin beta-4B chain | P01568 | IFNA21 | Interferon alpha-21 | -0.783 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | Q13509 | TUBB3 | Tubulin beta-3 chain | P01568 | IFNA21 | Interferon alpha-21 | -0.781 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | Q13509 | TUBB3 | Tubulin beta-3 chain | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.709 | P68371 | TUBB2C | Tubulin beta-4B chain | P01042 | KNG1 | Kininogen-1 | -0.7 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 |
| Mebendazole | hsa05202 | Transcriptional misregulation in cancer | 1.51E-05 | 15 | Q12778, Q15532, Q13315, P14780, P14923, Q16548, Q13489, Q13077, P08069, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, JUP, BCL2A1, BIRC3, TRAF1, IGF1R, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Mebendazole | hsa05203 | Viral carcinogenesis | 1.90E-02 | 6 | P06746, Q92830, P07948, P30279, P29083, Q93079 | POLB, KAT2A, LYN, CCND2, GTF2E1, H2BC9 | More | | Mebendazole | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa05210 | Colorectal cancer | 4.67E-02 | 4 | P84022, Q13485, P43246, O75293 | SMAD3, SMAD4, MSH2, GADD45B | More | | Mebendazole | hsa05212 | Pancreatic cancer | 3.46E-03 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Mebendazole | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Mebendazole | hsa05214 | Glioma | 3.39E-04 | 5 | P08069, P0DP23, Q16566, P17252, O75293 | IGF1R, CALM1, CAMK4, PRKCA, GADD45B | More | | Mebendazole | hsa05215 | Prostate cancer | 5.28E-04 | 6 | P10415, Q9UJU2, Q12778, P08069, Q9NRA1, P08238 | BCL2, LEF1, FOXO1, IGF1R, PDGFC, HSP90AB1 | More | | Mebendazole | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Mebendazole | hsa05222 | Small cell lung cancer | 3.10E-03 | 9 | Q13751, Q13489, P98170, P10415, P25963, Q13077, O00463, P24522, O75293 | LAMB3, BIRC3, BIRC4, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A, GADD45B | More | | Mebendazole | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | | Mebendazole | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Mebendazole | hsa05231 | Choline metabolism in cancer | 5.44E-03 | 4 | Q9NRA1, P23743, O14494, P17252 | PDGFC, DGKA, PLPP1, PRKCA | More | | Mebendazole | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.32E-04 | 8 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ | More | | Mebendazole | hsa05310 | Asthma | 3.88E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Mebendazole | hsa05321 | Inflammatory bowel disease | 1.28E-02 | 5 | O60603, P01375, P13765, Q14765, P23771 | TLR2, TNF, HLA-DOB, STAT4, GATA3 | More | | Mebendazole | hsa05322 | Systemic lupus erythematosus | 2.70E-03 | 10 | P08246, P08311, P01375, P10747, P13765, Q6FI13, P62807, Q16778, P12814, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2BC, HIST2H2BE, ACTN1, SSB | More | | Mebendazole | hsa05332 | Graft-versus-host disease | 9.30E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Mebendazole | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.17E-03 | 1 | P54284 | CACNB3 | More | | Mebendazole | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | | Mebendazole | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |